Tumour-initiating cells vs. cancer ‘stem’ cells and CD133: What’s in the name?
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 355 (4) , 855-859
- https://doi.org/10.1016/j.bbrc.2007.01.159
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicityInternational Journal of Cancer, 2007
- HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and TumorigenicityCurrent Biology, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Mammary stem and progenitor cells: Tumour precursors?European Journal Of Cancer, 2006
- Epidermal stem cells and cancer stem cells: Insights into cancer and potential therapeutic strategiesEuropean Journal Of Cancer, 2006
- Strategies to eliminate cancer stem cells: Clinical implicationsEuropean Journal Of Cancer, 2006
- Stem cell properties and epithelial malignanciesEuropean Journal Of Cancer, 2006
- Generation of a functional mammary gland from a single stem cellNature, 2006
- Purification and unique properties of mammary epithelial stem cellsNature, 2006
- The Hallmarks of CancerCell, 2000